Departament de Genètica i de Microbiologia, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.
SK8 Biotech, Parc Científic de Barcelona, Barcelona, Spain.
Front Cell Infect Microbiol. 2023 Sep 28;13:1266685. doi: 10.3389/fcimb.2023.1266685. eCollection 2023.
The emergence of resistance and interference mechanisms to phage infection can hinder the success of bacteriophage-based applications, but the significance of these mechanisms in phage therapy has not been determined. This work studies the emergence of isolates with reduced susceptibility to a cocktail of three phages under three scenarios: i) cultures (LAB), ii) biocontrol of cooked ham slices as a model of food safety (FOOD), and iii) oral phage therapy in broilers (PT).
. Typhimurium ATCC 14028 RifR variants with reduced phage susceptibility were isolated from the three scenarios and conventional and molecular microbiology techniques were applied to study them.
In LAB, 92% of isolates lost susceptibility to all three phages 24 h after phage infection. This percentage was lower in FOOD, with 4.3% of isolates not susceptible to at least two of the three phages after seven days at 4°C following phage treatment. In PT, 9.7% and 3.3 % of isolates from untreated and treated broilers, respectively, displayed some mechanism of interference with the life cycle of some of the phages. In LAB and FOOD scenarios, resistant variants carrying mutations in and genes involved in lipopolysaccharide synthesis (phage receptor) were identified. However, in PT, the significant decrease of EOP, ECOI, and burst size observed in isolates was prompted by lateral gene transfer of large IncI1 plasmids, which may encode phage defense mechanisms. These data indicate that the acquisition of specific conjugative plasmids has a stronger impact than mutagenesis on the emergence of reduced phage-susceptibility bacteria in certain environments. In spite of this, neither mechanism seems to significantly impair the success of biocontrol and oral phage therapy.
噬菌体感染的耐药和干扰机制的出现可能会阻碍噬菌体应用的成功,但这些机制在噬菌体治疗中的意义尚未确定。本研究在三种情况下研究了对三种噬菌体鸡尾酒敏感性降低的分离株的出现:i)培养物(LAB),ii)作为食品安全模型的熟火腿片的生物控制(FOOD),和 iii)肉鸡口服噬菌体治疗(PT)。
从三种情况下分离出对噬菌体敏感性降低的鼠伤寒沙门氏菌 ATCC 14028 RifR 变体,并应用常规和分子微生物学技术对其进行研究。
在 LAB 中,92%的分离株在噬菌体感染后 24 小时对所有三种噬菌体失去敏感性。在 FOOD 中,经过 7 天 4°C 噬菌体处理后,至少有两种噬菌体不敏感的分离株比例为 4.3%。在 PT 中,未经处理和处理的肉鸡中分别有 9.7%和 3.3%的分离株对某些噬菌体的生命周期存在某种干扰机制。在 LAB 和 FOOD 场景中,鉴定出携带参与脂多糖合成(噬菌体受体)的 和 基因突变的耐药变体。然而,在 PT 中,观察到的 EOP、ECOI 和爆发大小的显著降低是由携带可能编码噬菌体防御机制的大型 IncI1 质粒的水平基因转移引起的。这些数据表明,在某些环境中,特定的可转移质粒的获得比对噬菌体敏感性降低的细菌的突变更能影响其出现。尽管如此,这两种机制似乎都不会显著影响生物控制和口服噬菌体治疗的成功。